Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Anastasios Gkountakos"'
Autor:
Michele Bevere, Francesca Masetto, Maria Elena Carazzolo, Alice Bettega, Anastasios Gkountakos, Aldo Scarpa, Michele Simbolo
Publikováno v:
Diagnostics, Vol 13, Iss 17, p 2820 (2023)
Neuroendocrine neoplasms (NENs) are a heterogeneous group of diseases that are characterized by different behavior and clinical manifestations. The diagnosis and management of this group of tumors are challenging due to tumor complexity and lack of p
Externí odkaz:
https://doaj.org/article/a0df276f9d0f428e9d3132b9f95093b9
Autor:
Michele Bevere, Anastasios Gkountakos, Filippo Maria Martelli, Aldo Scarpa, Claudio Luchini, Michele Simbolo
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 303 (2023)
Pancreatic neuroendocrine neoplasms (PanNENs) are rare neoplasms arising from islets of the Langerhans in the pancreas. They can be divided into two groups, based on peptide hormone secretion, functioning and nonfunctioning PanNENs. The first group i
Externí odkaz:
https://doaj.org/article/67d624a2b2f94681b87a866ce7aad0c8
Autor:
Anastasios Gkountakos, Pietro Delfino, Rita T. Lawlor, Aldo Scarpa, Vincenzo Corbo, Emilio Bria
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
The introduction of immune checkpoint inhibitor (ICI)-based therapy for non-oncogene addicted non-small cell lung cancer (NSCLC) has significantly transformed the treatment landscape of the disease. Inhibitors of the programmed cell death protein 1/p
Externí odkaz:
https://doaj.org/article/15efe01644ea4de18c658fa8d5575992
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 3, p 1283 (2022)
Undifferentiated sarcomatoid carcinoma of the pancreas (SCP) is a rare and aggressive subtype of pancreatic cancer. Histologically, SCP is a poorly differentiated tumor characterized by the lack of glandular differentiation and the presence of mesenc
Externí odkaz:
https://doaj.org/article/1fa26e3f0d3f47bdb987cab77ce3ef7d
Autor:
Anastasios Gkountakos, Giovanni Centonze, Emanuele Vita, Lorenzo Belluomini, Michele Milella, Emilio Bria, Massimo Milione, Aldo Scarpa, Michele Simbolo
Publikováno v:
Biomedicines, Vol 10, Iss 2, p 277 (2022)
The use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) as first-line treatment in patients with lung adenocarcinoma (LUAD) harboring EGFR-activating mutations has resulted in a dramatic improvement in the management of t
Externí odkaz:
https://doaj.org/article/05e851a8ade44b2881384324610425ea
Autor:
Anastasios Gkountakos, Filippo M. Martelli, Nicola Silvestris, Michele Bevere, Mario De Bellis, Laura Alaimo, Elena Sapuppo, Francesca Masetto, Aldo Mombello, Michele Simbolo, Elena Bariani, Michele Milella, Matteo Fassan, Aldo Scarpa, Claudio Luchini
Pancreatic ductal adenocarcinoma (PDAC) and distal cholangiocarcinoma (dCCA) are very aggressive tumors with a high mortality rate. Pancreas and distal bile ducts share a common embryonic development. Hence, PDAC and dCCA exhibit similar histological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23e912ee906b1d407ec4aac965c416b9
https://hdl.handle.net/11577/3475641
https://hdl.handle.net/11577/3475641
Autor:
Michele Simbolo, Giovanni Centonze, Luca Giudice, Federica Grillo, Patrick Maisonneuve, Anastasios Gkountakos, Chiara Ciaparrone, Laura Cattaneo, Giovanna Sabella, Rosalba Giugno, Paola Bossi, Paola Spaggiari, Alessandro Del Gobbo, Stefano Ferrero, Luca Mastracci, Alessandra Fabbri, Martina Filugelli, Giovanna Garzone, Natalie Prinzi, Sara Pusceddu, Adele Testi, Valentina Monti, Luigi Rolli, Alessandro Mangogna, Luisa Bercich, Mauro Roberto Benvenuti, Emilio Bria, Sara Pilotto, Alfredo Berruti, Ugo Pastorino, Carlo Capella, Maurizio Infante, Michele Milella, Aldo Scarpa, Massimo Milione
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4653
Simple Summary In this manuscript, we offer an integrated molecular analysis of 44 combined large cell neuroendocrine carcinomas (CoLCNECs) in order to deepen the knowledge about these rare histotypes and to clarify their relationship with lung cance
Autor:
Anastasios Gkountakos, Andrea Mafficini, Emil Lou, Giuseppe Malleo, Roberto Salvia, Martina Calicchia, Nicola Silvestris, Emilian Racila, Khalid Amin, Nicola Veronese, Oronzo Brunetti, Pietro Antonini, Giuseppe Ingravallo, Paola Mattiolo, Concetta Saponaro, Floriana Nappo, Michele Simbolo, Elena Bariani, Sara Lonardi, Matteo Fassan, Michele Milella, Rita T. Lawlor, Aldo Scarpa, Claudio Luchini
Undifferentiated sarcomatoid carcinoma (USC) of the pancreas is a rare but especially aggressive variant of pancreatic ductal adenocarcinoma (PDAC), composed of at least 80% of sarcomatoid cells. This study aimed to elucidate its clinicopathological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0118d1e814f654a33b822cec6365fe1
http://hdl.handle.net/11577/3454437
http://hdl.handle.net/11577/3454437
Autor:
Anastasios, Gkountakos, Giovanni, Centonze, Emanuele, Vita, Lorenzo, Belluomini, Michele, Milella, Emilio, Bria, Massimo, Milione, Aldo, Scarpa, Michele, Simbolo
Publikováno v:
Biomedicines. 10(2)
The use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) as first-line treatment in patients with lung adenocarcinoma (LUAD) harboring EGFR-activating mutations has resulted in a dramatic improvement in the management of t
Autor:
Santiago Viteri, Peng Cao, Claudio Dazzi, Anastasios Gkountakos, Filippo de Marinis, Niki Karachaliou, Sara Pilotto, Mariacarmela Santarpia, Chiara Lazzari, Rafael Rosell, Daniela Morales-Espinosa, José Serrano, Imane Chaib, Alberto Verlicchi
Innovative therapeutic agents have significantly improved outcomes, with an acceptable safety profile, in a substantial proportion of non-small cell lung cancer (NSCLC) patients in whom the malignant phenotype of the disease is determined by oncogeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d81b1bf613f019a8c1cc45a49b2d9b2
http://hdl.handle.net/11562/974620
http://hdl.handle.net/11562/974620